1. Home
  2. TVTX vs HWKN Comparison

TVTX vs HWKN Comparison

Compare TVTX & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travere Therapeutics Inc.

TVTX

Travere Therapeutics Inc.

HOLD

Current Price

$28.06

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$149.88

Market Cap

3.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TVTX
HWKN
Founded
N/A
1938
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
2013
1995

Fundamental Metrics

Financial Performance
Metric
TVTX
HWKN
Price
$28.06
$149.88
Analyst Decision
Strong Buy
Buy
Analyst Count
14
2
Target Price
$36.85
$200.00
AVG Volume (30 Days)
1.3M
98.7K
Earning Date
05-11-2026
04-28-2026
Dividend Yield
N/A
0.50%
EPS Growth
92.89
12.26
EPS
N/A
3.17
Revenue
N/A
$974,431,000.00
Revenue This Year
$44.75
$12.37
Revenue Next Year
$26.82
$6.30
P/E Ratio
N/A
$47.71
Revenue Growth
N/A
6.01
52 Week Low
$12.91
$100.35
52 Week High
$42.13
$186.15

Technical Indicators

Market Signals
Indicator
TVTX
HWKN
Relative Strength Index (RSI) 40.24 57.70
Support Level $27.01 $150.01
Resistance Level $31.47 $151.83
Average True Range (ATR) 1.64 5.24
MACD -0.02 0.87
Stochastic Oscillator 25.89 75.30

Price Performance

Historical Comparison
TVTX
HWKN

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

Share on Social Networks: